Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:2975-2979
Published online before print August 7, 2008, doi: 10.1161/STROKEAHA.108.515262
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/11/2975    most recent
STROKEAHA.108.515262v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, T. J.
Right arrow Articles by Lees, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, T. J.
Right arrow Articles by Lees, K. R.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Primary and Secondary Stroke Prevention

(Stroke. 2008;39:2975.)
© 2008 American Heart Association, Inc.


Original Contributions

Variability in Modified Rankin Scoring Across a Large Cohort of International Observers

Terence J. Quinn, MRCP; Jesse Dawson, MRCP; Matthew R. Walters, MD Kennedy R. Lees, MD

From the Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Correspondence to Terence J. Quinn, MRCP, Gardiner Institute of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary, Church Street, Glasgow G11 6NT, UK. E-mail Tjq1t{at}clinmed.gla.ac.uk

Background and Purpose— The modified Rankin scale (mRS) is the most commonly used outcome measure in stroke trials. However, substantial interobserver variability in mRS scoring has been reported. These studies likely underestimate the variability present in multicenter clinical trials, because exploratory work has only been undertaken in single centers by a few observers, all of similar training. We examined mRS variability across a large cohort of international observers using data from a video training resource.

Methods— The mRS training package includes a series of "real-life" patient interviews for grading. Training data were collected centrally and analyzed for variability using kappa statistics. We examined variability against a standard of "correct" mRS grades; examined variability by country; and for UK assessors, examined variability by center and by professional background of the observer.

Results— To date, 2942 assessments from 30 countries have been submitted. Overall reliability for mRS grading has been moderate to good with substantial heterogeneity across countries. Native English language has had little effect on reliability. Within the United Kingdom, there was no significant variation by profession.

Conclusion— Our results confirm interobserver variability in mRS assessment. The heterogeneity across countries is intriguing because it appears not to be related solely to language. These data highlight the need for novel strategies to improve reliability.


Key Words: clinical trials • modified Rankin Score • outcome assessment • stroke




This article has been cited by other articles:


Home page
StrokeHome page
T. J. Quinn, J. Dawson, M. R. Walters, and K. R. Lees
Reliability of the Modified Rankin Scale: A Systematic Review
Stroke, October 1, 2009; 40(10): 3393 - 3395.
[Abstract] [Full Text] [PDF]